phacidin has been researched along with 4-chloro-3-(2,4-dihydroxyphenylazo)-2-hydroxybenzene-1-sulfonic acid in 1 studies
| Studies (phacidin) | Trials (phacidin) | Recent Studies (post-2010) (phacidin) | Studies (4-chloro-3-(2,4-dihydroxyphenylazo)-2-hydroxybenzene-1-sulfonic acid) | Trials (4-chloro-3-(2,4-dihydroxyphenylazo)-2-hydroxybenzene-1-sulfonic acid) | Recent Studies (post-2010) (4-chloro-3-(2,4-dihydroxyphenylazo)-2-hydroxybenzene-1-sulfonic acid) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 19 | 0 | 9 |
| Protein | Taxonomy | phacidin (IC50) | 4-chloro-3-(2,4-dihydroxyphenylazo)-2-hydroxybenzene-1-sulfonic acid (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 58.3 | |
| integrase, partial | Human immunodeficiency virus 1 | 9.939 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 9.939 | |
| nonstructural protein 1 | Influenza A virus (A/California/07/2009(H1N1)) | 8.301 | |
| matrix metalloproteinase-14 preproprotein | Homo sapiens (human) | 1.41 | |
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 83.74 | |
| Vif | Human immunodeficiency virus 1 | 49.44 | |
| Tat | Human immunodeficiency virus 1 | 22.503 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 49.44 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorjsuren, D; Egli, M; Eoff, RL; Jadhav, A; Lloyd, RS; Maloney, DJ; Simeonov, A; Yamanaka, K | 1 |
1 other study(ies) available for phacidin and 4-chloro-3-(2,4-dihydroxyphenylazo)-2-hydroxybenzene-1-sulfonic acid
| Article | Year |
|---|---|
A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κ.
Topics: Acrolein; Benzimidazoles; Biphenyl Compounds; Cell Line, Transformed; Cell Survival; Deoxyguanosine; DNA; DNA Adducts; DNA Damage; DNA Repair; DNA-Directed DNA Polymerase; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Indoles; Nucleic Acid Synthesis Inhibitors; Small Molecule Libraries; Terpenes; Tetrazoles; Ultraviolet Rays | 2012 |